Literature DB >> 3161830

Stimulation of immunoglobulin-containing cells and isotype-specific antibody response in experimental Mycoplasma hyopneumoniae infection in specific-pathogen-free pigs.

M Suter, M Kobisch, J Nicolet.   

Abstract

The development of immunoglobulin-containing cells and antigen-specific plasma cells in retropharyngeal and bronchial lymph nodes, in lung tissue, and in nasal mucous membrane was followed during an experimental infection of pigs with Mycoplasma hyopneumoniae. An enzyme-linked immunosorbent assay was used to follow stimulation of the immunoglobulin isotypes (classes) M, G, and A directed against the infectious agent in tracheobronchial secretions and systemically. A significant increase of antigen-specific plasma cells in lymph nodes and lung tissue as well as antibodies in tracheobronchial secretions was demonstrated 2 weeks after infection. This specific reaction was followed by a marked increase of immunoglobulin-containing cells in lymph nodes and lung tissue. The data are discussed in terms of autoimmune reactions in the pathogenesis of enzootic pneumonia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161830      PMCID: PMC261224          DOI: 10.1128/iai.49.3.615-620.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Complement-fixation tests in the diagnosis of enzootic pneumonia of pigs. II. Field studies.

Authors:  R T Hodges; A O Betts
Journal:  Vet Rec       Date:  1969-10-25       Impact factor: 2.695

2.  Tween 20 soluble proteins of Mycoplasma hyopneumoniae as antigen for an enzyme linked immunosorbent assay.

Authors:  J Nicolet; P Paroz; S Bruggmann
Journal:  Res Vet Sci       Date:  1980-11       Impact factor: 2.534

3.  [On hemophilosis of the pig. IV. Complement deviation, a test for the detection of Haemophilus parahaemolyticus infections].

Authors:  J Nicolet; P A de Meuron; P Bachmann
Journal:  Schweiz Arch Tierheilkd       Date:  1971-04       Impact factor: 0.845

4.  Histological immunoenzyme techniques in canine tissues: evaluation of various methods and modifications.

Authors:  M Vandevelde; E Hugi; A Isler; M Suter; H Pfister
Journal:  Res Vet Sci       Date:  1983-03       Impact factor: 2.534

5.  Immunoglobulin levels in porcine nasal and tracheal secretions--the influence of the method of collection.

Authors:  K L Morgan; F J Bourne
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Pharmacokinetics of oxytetracycline and therapeutic implications in veal calves.

Authors:  D Schifferli; R L Galeazzi; J Nicolet; M Wanner
Journal:  J Vet Pharmacol Ther       Date:  1982-12       Impact factor: 1.786

7.  Detection of antibodies against membrane-glycoproteins of swine erythrocytes after experimental infection with Mycoplasma hyopneumoniae.

Authors:  A Baumgartner; J Nicolet
Journal:  Vet Immunol Immunopathol       Date:  1984-08       Impact factor: 2.046

8.  An enzyme-linked immunosorbent assay, using an EDTA-extracted antigen for the serology of Haemophilus pleuropneumoniae.

Authors:  J Nicolet; P Paroz; M Krawinkler; A Baumgartner
Journal:  Am J Vet Res       Date:  1981-12       Impact factor: 1.156

9.  A modified ELISA technique for anti-hapten antibodies.

Authors:  M Suter
Journal:  J Immunol Methods       Date:  1982-08-27       Impact factor: 2.303

10.  Allergen-specific ELISA for horse IgE.

Authors:  M Suter; H Fey
Journal:  Vet Immunol Immunopathol       Date:  1983-07       Impact factor: 2.046

View more
  2 in total

1.  Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia.

Authors:  E L Thacker; P G Halbur; R F Ross; R Thanawongnuwech; B J Thacker
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

2.  Potential use of local and systemic humoral immune response parameters to forecast Mycoplasma hyopneumoniae associated lung lesions.

Authors:  Beatriz Garcia-Morante; Joaquim Segalés; Lorenzo Fraile; Gemma Llardén; Teresa Coll; Marina Sibila
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.